Surya Pharma

Rediff.com » News » Surya Pharma

News for Surya Pharma

Business

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Market litmus may turn red for chemicals sector

The chemicals sector’s recovery could be delayed until FY25 if the current trends of weak demand and flat pricing continue. Photograph: Lisi Niesner/Reuters Following a subdued September......

Why Dr Reddy's expects FY19 to be stronger and richer

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015 Investors......

Drug firms on outsourcing high

An increase in the number of outsourcing deals between domestic drug companies and pharmaceutical multinationals has triggered huge capacity expansion programmes in the drug manufacturing......

Stocks that you can buy, sell or hold

The markets remained volatile the first two days of the week. However, on Wednesday it has traded in the positive region from the start of the trading hour. Will the Sensex move up from this point?......

Rediff News

Surya Pharma

News for Surya Pharma

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Market litmus may turn red for chemicals sector

Why Dr Reddy's expects FY19 to be stronger and richer

Drug firms on outsourcing high

Stocks that you can buy, sell or hold

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS